Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Net Income towards Common Stockholders (2021 - 2025)

Historic Net Income towards Common Stockholders for Dare Bioscience (DARE) over the last 8 years, with Q3 2025 value amounting to -$3.7 million.

  • Dare Bioscience's Net Income towards Common Stockholders rose 2155.79% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.4 million, marking a year-over-year increase of 2493.42%. This contributed to the annual value of -$4.1 million for FY2024, which is 8656.03% up from last year.
  • Latest data reveals that Dare Bioscience reported Net Income towards Common Stockholders of -$3.7 million as of Q3 2025, which was up 2155.79% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Net Income towards Common Stockholders registered a high of $384322.0 during Q2 2022, and its lowest value of -$15.9 million during Q4 2022.
  • For the 5-year period, Dare Bioscience's Net Income towards Common Stockholders averaged around -$7.1 million, with its median value being -$7.0 million (2022).
  • Per our database at Business Quant, Dare Bioscience's Net Income towards Common Stockholders skyrocketed by 10419.43% in 2022 and then plummeted by 243901.68% in 2023.
  • Quarter analysis of 5 years shows Dare Bioscience's Net Income towards Common Stockholders stood at -$9.5 million in 2021, then tumbled by 67.07% to -$15.9 million in 2022, then soared by 68.28% to -$5.1 million in 2023, then dropped by 6.54% to -$5.4 million in 2024, then surged by 31.85% to -$3.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$3.7 million for Q3 2025, versus -$3.8 million for Q2 2025 and -$4.6 million for Q1 2025.